| Jeffrey Clegg, MD | |
|
75 Francis St, Boston, MA 02115-6106 | |
| (617) 732-5500 | |
| Not Available |
| Full Name | Jeffrey Clegg |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 75 Francis St, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154853133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 1015579 (Massachusetts) | Primary |
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Entity Name | Cd Practice Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295787919 PECOS PAC ID: 2567359839 Enrollment ID: O20040302000290 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Entity Name | Harbor Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079561 PECOS PAC ID: 2466356209 Enrollment ID: O20040719000954 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Entity Name | Cooley Dickinson Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477596310 PECOS PAC ID: 8123090560 Enrollment ID: O20040806001098 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Clegg, MD 3027 Central St Se, Olympia, WA 98501-3627 Ph: (360) 701-6994 | Jeffrey Clegg, MD 75 Francis St, Boston, MA 02115-6106 Ph: (617) 732-5500 |
News Archive
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.
"Health care in America is too costly – for individuals, for employers and for our country. It is the number one cost pressure facing our members, who provide coverage to more than 35 million Americans, which is why we have been at the table since day one advocating for effective systemic reform.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food
› Verified 9 days ago
Jennifer Michelle Thomas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Department Of Radiology, Boston, MA 02115 Phone: 617-732-6248 | |
Dr. Meghavi Mashar, MB BCHIR Radiology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Rafeeque A Bhadelia, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Bidmc Wcc90, Boston, MA 02215 Phone: 617-754-2058 Fax: 617-754-2004 | |
Dr. Srinivasan Mukundan Jr., M.D. Radiology Medicare: Medicare Enrolled Practice Location: 75 Francis St, Brigham And Women's Hospital, Boston, MA 02115 Phone: 617-732-7260 | |
Raymond W Liu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Grb 293, Boston, MA 02114 Phone: 917-923-2079 | |
Dr. Hillary R. Kelly, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Grb-273a, Boston, MA 02114 Phone: 617-726-8320 Fax: 617-724-3338 | |
Dr. Tina Young Poussaint, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6450 |